These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18932194)

  • 21. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
    Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
    Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
    Lee MY; Jo SD; Lee JH; Han HJ
    J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of class IA PI3Ks.
    Wu H; Yan Y; Backer JM
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):242-4. PubMed ID: 17371249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation.
    Ng SK; Neo SY; Yap YW; Karuturi RK; Loh ES; Liau KH; Ren EC
    Biochem Biophys Res Commun; 2009 Sep; 387(2):310-5. PubMed ID: 19591801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells.
    De Santis G; Miotti S; Mazzi M; Canevari S; Tomassetti A
    Oncogene; 2009 Mar; 28(9):1206-17. PubMed ID: 19151754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
    Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
    Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
    Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
    Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the transition from the meiotic to mitotic cell cycle during early mouse development.
    Kubiak JZ; Ciemerych MA; Hupalowska A; Sikora-Polaczek M; Polanski Z
    Int J Dev Biol; 2008; 52(2-3):201-17. PubMed ID: 18311711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transforming functions of PI3-kinase-gamma are linked to disruption of intercellular adhesion and promotion of cancer cell invasion.
    Attoub S; De Wever O; Bruyneel E; Mareel M; Gespach C
    Ann N Y Acad Sci; 2008 Sep; 1138():204-13. PubMed ID: 18837901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The class IA phosphatidylinositol 3-kinase p110-beta subunit is a positive regulator of autophagy.
    Dou Z; Chattopadhyay M; Pan JA; Guerriero JL; Jiang YP; Ballou LM; Yue Z; Lin RZ; Zong WX
    J Cell Biol; 2010 Nov; 191(4):827-43. PubMed ID: 21059846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma.
    Czupalla C; Culo M; Müller EC; Brock C; Reusch HP; Spicher K; Krause E; Nürnberg B
    J Biol Chem; 2003 Mar; 278(13):11536-45. PubMed ID: 12502714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class I PI3K in oncogenic cellular transformation.
    Zhao L; Vogt PK
    Oncogene; 2008 Sep; 27(41):5486-96. PubMed ID: 18794883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal regulation of the first mitosis in Xenopus and mouse embryos.
    Kubiak JZ; Chesnel F; Richard-Parpaillon L; Bazile F; Pascal A; Polanski Z; Sikora-Polaczek M; Maciejewska Z; Ciemerych MA
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):63-9. PubMed ID: 18178304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development.
    Li T; Inoue A; Lahti JM; Kidd VJ
    Mol Cell Biol; 2004 Apr; 24(8):3188-97. PubMed ID: 15060143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.